Sol-Gel Technologies (SLGL) Total Current Liabilities (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Total Current Liabilities of $6.3 million for Q1 2026, up 38.05% year-over-year from $4.6 million in Q1 2025, and up 2.3% quarter-over-quarter from $6.2 million in Q4 2025.

Sol-Gel Technologies (SLGL) Total Current Liabilities (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Total Current Liabilities data on file, last reported at $6.3 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $6.3 million, up 38.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 38.05% YoY), and the FY2025 annual result was $6.2 million, up 16.76% from the prior year.
  • Total Current Liabilities rose to $6.3 million in Q1 2026 per SLGL's latest filing, from $6.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $6.5 million in Q3 2024 and troughed at $2.6 million in Q3 2022.
  • A 5-year average of $4.8 million and a median of $5.0 million in 2025 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Current Liabilities sank 72.74% in 2022, then soared 75.72% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $3.3 million in 2022, then jumped by 35.84% to $4.5 million in 2023, then rose by 16.87% to $5.3 million in 2024, then climbed by 16.76% to $6.2 million in 2025, then rose by 2.3% to $6.3 million in 2026.
  • Business Quant data shows SLGL's Total Current Liabilities at $6.3 million in Q1 2026, $6.2 million in Q4 2025, and $6.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 6.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.31 Mn
Dec 31, 2025 6.17 Mn
Sep 30, 2025 6.15 Mn
Jun 30, 2025 4.96 Mn
Mar 31, 2025 4.57 Mn
Dec 31, 2024 5.29 Mn
Sep 30, 2024 6.53 Mn
Jun 30, 2024 5.20 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 4.52 Mn
Sep 30, 2023 4.51 Mn
Jun 30, 2023 5.67 Mn
Mar 31, 2023 3.92 Mn
Dec 31, 2022 3.33 Mn
Sep 30, 2022 2.60 Mn
Jun 30, 2022 3.23 Mn
Mar 31, 2022 4.21 Mn
Dec 31, 2021 11.69 Mn
Sep 30, 2021 9.53 Mn
Jun 30, 2021 5.16 Mn